Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.32

+2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	11/27/2009 4:57:34 PM
	Read Replies (2) of 52153

More Zamboni. Peter, Do you still feel that it's unlikely that Venal blockage/restriction is unlikely to be the root cause of MS? I still haven’t seen the Clinical Study of the treated patients but I’ve seen comments from some who have. Perhaps, the paper will show up in the December volume of the Journal of Vascular Surgery which isn't online yet. 1. MS lesions are symmetrical, adjacent to and follow a blocked vein. 2. About 75% of those treated are relapse and symptom free more than a year after surgery 3. Those that relapse have restenosis in one or more of the veins which had stenosis. After retreating the vein, the relapse ends and healing resumes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next